Insiders · Profile

McCombe William D.

Chief Financial Officer at Cytek Biosciences · Chief Financial Officer at Velo3D. Filing since 16 Nov 2022. CIK 0001878824

Company
Date
Role
Action
Shares
Amount
Of holding
2 Jun 2025
Chief Financial Officer
Bought
35,000
$97.30K
169%
21 Aug 2023
Chief Financial Officer
Sold at will
11,201
$16.69K
6.2%
15 May 2023
Chief Financial Officer
Sold at will
11,198
$20.81K
6.9%
15 Feb 2023
Chief Financial Officer
Sold, plan not stated
4,268
$15.45K
3.2%
16 Nov 2022
Chief Financial Officer
Sold, plan not stated
14,470
$37.83K
10.4%
5 decisions on file.